Global Small Molecule Anti-tumor Targted Drug Market Insights and Forecast to 2031

Report ID: 1639342 | Published Date: Jan 2026 | No. of Page: 106 | Base Year: 2025 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 EGFR
        1.2.3 ALK
        1.2.4 Bcr-Abl
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Liver Cancer
        1.3.3 Colorectal Cancer
        1.3.4 Lung Cancer
        1.3.5 Gastric Cancer
        1.3.6 Breast Cancer
        1.3.7 Esophageal Cancer
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Small Molecule Anti-tumor Targted Drug Market Perspective (2017-2028)
    2.2 Small Molecule Anti-tumor Targted Drug Growth Trends by Region
        2.2.1 Small Molecule Anti-tumor Targted Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Small Molecule Anti-tumor Targted Drug Historic Market Size by Region (2017-2022)
        2.2.3 Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Region (2023-2028)
    2.3 Small Molecule Anti-tumor Targted Drug Market Dynamics
        2.3.1 Small Molecule Anti-tumor Targted Drug Industry Trends
        2.3.2 Small Molecule Anti-tumor Targted Drug Market Drivers
        2.3.3 Small Molecule Anti-tumor Targted Drug Market Challenges
        2.3.4 Small Molecule Anti-tumor Targted Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Revenue
        3.1.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Revenue (2017-2022)
        3.1.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Small Molecule Anti-tumor Targted Drug Revenue
    3.4 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio
        3.4.1 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Anti-tumor Targted Drug Revenue in 2021
    3.5 Small Molecule Anti-tumor Targted Drug Key Players Head office and Area Served
    3.6 Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service
    3.7 Date of Enter into Small Molecule Anti-tumor Targted Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Anti-tumor Targted Drug Breakdown Data by Type
    4.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Type (2017-2022)
    4.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2023-2028)
5 Small Molecule Anti-tumor Targted Drug Breakdown Data by Application
    5.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Application (2017-2022)
    5.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Small Molecule Anti-tumor Targted Drug Market Size (2017-2028)
    6.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type
        6.2.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)
        6.2.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028)
        6.2.3 North America Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028)
    6.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Application
        6.3.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)
        6.3.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028)
        6.3.3 North America Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028)
    6.4 North America Small Molecule Anti-tumor Targted Drug Market Size by Country
        6.4.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022)
        6.4.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Small Molecule Anti-tumor Targted Drug Market Size (2017-2028)
    7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type
        7.2.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)
        7.2.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028)
        7.2.3 Europe Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028)
    7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application
        7.3.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)
        7.3.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028)
        7.3.3 Europe Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028)
    7.4 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country
        7.4.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022)
        7.4.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size (2017-2028)
    8.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type
        8.2.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application
        8.3.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region
        8.4.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size (2017-2028)
    9.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type
        9.2.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028)
    9.3 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application
        9.3.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028)
    9.4 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country
        9.4.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size (2017-2028)
    10.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type
        10.2.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application
        10.3.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country
        10.4.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Astrazeneca
        11.1.1 Astrazeneca Company Details
        11.1.2 Astrazeneca Business Overview
        11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Introduction
        11.1.4 Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.1.5 Astrazeneca Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Small Molecule Anti-tumor Targted Drug Introduction
        11.2.4 Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Millennium Pharmaceuticals
        11.3.1 Millennium Pharmaceuticals Company Details
        11.3.2 Millennium Pharmaceuticals Business Overview
        11.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Introduction
        11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.3.5 Millennium Pharmaceuticals Recent Developments
    11.4 Bayer
        11.4.1 Bayer Company Details
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Introduction
        11.4.4 Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.4.5 Bayer Recent Developments
    11.5 Exelixis
        11.5.1 Exelixis Company Details
        11.5.2 Exelixis Business Overview
        11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Introduction
        11.5.4 Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.5.5 Exelixis Recent Developments
    11.6 Abbvie
        11.6.1 Abbvie Company Details
        11.6.2 Abbvie Business Overview
        11.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Introduction
        11.6.4 Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.6.5 Abbvie Recent Developments
    11.7 Boehringer-Ingelheim
        11.7.1 Boehringer-Ingelheim Company Details
        11.7.2 Boehringer-Ingelheim Business Overview
        11.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Introduction
        11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.7.5 Boehringer-Ingelheim Recent Developments
    11.8 Eisai
        11.8.1 Eisai Company Details
        11.8.2 Eisai Business Overview
        11.8.3 Eisai Small Molecule Anti-tumor Targted Drug Introduction
        11.8.4 Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.8.5 Eisai Recent Developments
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Introduction
        11.9.4 Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.9.5 Pfizer Recent Developments
    11.10 Bristol-Myers Squibb
        11.10.1 Bristol-Myers Squibb Company Details
        11.10.2 Bristol-Myers Squibb Business Overview
        11.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Introduction
        11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.10.5 Bristol-Myers Squibb Recent Developments
    11.11 Roche
        11.11.1 Roche Company Details
        11.11.2 Roche Business Overview
        11.11.3 Roche Small Molecule Anti-tumor Targted Drug Introduction
        11.11.4 Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.11.5 Roche Recent Developments
    11.12 Bettapharma
        11.12.1 Bettapharma Company Details
        11.12.2 Bettapharma Business Overview
        11.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Introduction
        11.12.4 Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
        11.12.5 Bettapharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of EGFR
    Table 3. Key Players of ALK
    Table 4. Key Players of Bcr-Abl
    Table 5. Key Players of Others
    Table 6. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Small Molecule Anti-tumor Targted Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Small Molecule Anti-tumor Targted Drug Market Share by Region (2017-2022)
    Table 10. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Small Molecule Anti-tumor Targted Drug Market Share by Region (2023-2028)
    Table 12. Small Molecule Anti-tumor Targted Drug Market Trends
    Table 13. Small Molecule Anti-tumor Targted Drug Market Drivers
    Table 14. Small Molecule Anti-tumor Targted Drug Market Challenges
    Table 15. Small Molecule Anti-tumor Targted Drug Market Restraints
    Table 16. Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Players (2017-2022)
    Table 18. Global Top Small Molecule Anti-tumor Targted Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2021)
    Table 19. Ranking of Global Top Small Molecule Anti-tumor Targted Drug Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service
    Table 23. Date of Enter into Small Molecule Anti-tumor Targted Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2017-2022)
    Table 27. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2023-2028)
    Table 29. Global Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Application (2017-2022)
    Table 31. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Application (2023-2028)
    Table 33. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Astrazeneca Company Details
    Table 64. Astrazeneca Business Overview
    Table 65. Astrazeneca Small Molecule Anti-tumor Targted Drug Product
    Table 66. Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 67. Astrazeneca Recent Developments
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Small Molecule Anti-tumor Targted Drug Product
    Table 71. Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 72. Novartis Recent Developments
    Table 73. Millennium Pharmaceuticals Company Details
    Table 74. Millennium Pharmaceuticals Business Overview
    Table 75. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product
    Table 76. Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 77. Millennium Pharmaceuticals Recent Developments
    Table 78. Bayer Company Details
    Table 79. Bayer Business Overview
    Table 80. Bayer Small Molecule Anti-tumor Targted Drug Product
    Table 81. Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 82. Bayer Recent Developments
    Table 83. Exelixis Company Details
    Table 84. Exelixis Business Overview
    Table 85. Exelixis Small Molecule Anti-tumor Targted Drug Product
    Table 86. Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 87. Exelixis Recent Developments
    Table 88. Abbvie Company Details
    Table 89. Abbvie Business Overview
    Table 90. Abbvie Small Molecule Anti-tumor Targted Drug Product
    Table 91. Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 92. Abbvie Recent Developments
    Table 93. Boehringer-Ingelheim Company Details
    Table 94. Boehringer-Ingelheim Business Overview
    Table 95. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product
    Table 96. Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 97. Boehringer-Ingelheim Recent Developments
    Table 98. Eisai Company Details
    Table 99. Eisai Business Overview
    Table 100. Eisai Small Molecule Anti-tumor Targted Drug Product
    Table 101. Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 102. Eisai Recent Developments
    Table 103. Pfizer Company Details
    Table 104. Pfizer Business Overview
    Table 105. Pfizer Small Molecule Anti-tumor Targted Drug Product
    Table 106. Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 107. Pfizer Recent Developments
    Table 108. Bristol-Myers Squibb Company Details
    Table 109. Bristol-Myers Squibb Business Overview
    Table 110. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product
    Table 111. Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 112. Bristol-Myers Squibb Recent Developments
    Table 113. Roche Company Details
    Table 114. Roche Business Overview
    Table 115. Roche Small Molecule Anti-tumor Targted Drug Product
    Table 116. Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 117. Roche Recent Developments
    Table 118. Bettapharma Company Details
    Table 119. Bettapharma Business Overview
    Table 120. Bettapharma Small Molecule Anti-tumor Targted Drug Product
    Table 121. Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million)
    Table 122. Bettapharma Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Small Molecule Anti-tumor Targted Drug Market Share by Type: 2021 VS 2028
    Figure 2. EGFR Features
    Figure 3. ALK Features
    Figure 4. Bcr-Abl Features
    Figure 5. Others Features
    Figure 6. Global Small Molecule Anti-tumor Targted Drug Market Share by Application: 2021 VS 2028
    Figure 7. Liver Cancer Case Studies
    Figure 8. Colorectal Cancer Case Studies
    Figure 9. Lung Cancer Case Studies
    Figure 10. Gastric Cancer Case Studies
    Figure 11. Breast Cancer Case Studies
    Figure 12. Esophageal Cancer Case Studies
    Figure 13. Others Case Studies
    Figure 14. Small Molecule Anti-tumor Targted Drug Report Years Considered
    Figure 15. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Small Molecule Anti-tumor Targted Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Small Molecule Anti-tumor Targted Drug Market Share by Region: 2021 VS 2028
    Figure 18. Global Small Molecule Anti-tumor Targted Drug Market Share by Players in 2021
    Figure 19. Global Top Small Molecule Anti-tumor Targted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue in 2021
    Figure 21. North America Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028)
    Figure 23. North America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028)
    Figure 24. North America Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028)
    Figure 25. United States Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028)
    Figure 31. Germany Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Share by Region (2017-2028)
    Figure 41. China Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028)
    Figure 51. Mexico Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028)
    Figure 57. Turkey Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Astrazeneca Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 62. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 63. Bayer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 64. Exelixis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 65. Abbvie Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 66. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 67. Eisai Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 68. Pfizer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 70. Roche Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 71. Bettapharma Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Frequently Asked Questions
Small Molecule Anti-tumor Targted Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Small Molecule Anti-tumor Targted Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Small Molecule Anti-tumor Targted Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

TLSO

TLSO market is segmented by Type and by Application. Players, stakeholders, and other participant ... Read More